Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.1%

3 terminated/withdrawn out of 142 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

11%

16 trials in Phase 3/4

Results Transparency

2%

1 of 54 completed trials have results

Key Signals

29 recruiting1 with results

Enrollment Performance

Analytics

N/A
52(66.7%)
Phase 4
10(12.8%)
Phase 2
8(10.3%)
Phase 3
6(7.7%)
Early Phase 1
1(1.3%)
Phase 1
1(1.3%)
78Total
N/A(52)
Phase 4(10)
Phase 2(8)
Phase 3(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (142)

Showing 20 of 142 trials
NCT04806906Phase 2Completed

Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients

Role: lead

NCT06135753Not ApplicableRecruiting

Psychosomatic Intervention in Fibromyalgia.

Role: lead

NCT07404410Not ApplicableRecruiting

Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)

Role: collaborator

NCT03404336Not ApplicableRecruiting

Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy

Role: lead

NCT07251517Not ApplicableCompleted

Cognitive Rehabilitation in Post-stroke Cognitive Impairment

Role: lead

NCT06403631Completed

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Role: collaborator

NCT06797050Not ApplicableRecruiting

A Story for Pepper & Nao

Role: collaborator

NCT07398781Not ApplicableRecruiting

PACE Study: School-Based Mindfulness and Compassion Interventions for Children

Role: collaborator

NCT07422636Completed

Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study

Role: lead

NCT05903040Completed

Ditan Acute tReatments: Effectiveness and Tolerability (DART)

Role: lead

NCT06628921Recruiting

The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)

Role: lead

NCT06414044Active Not Recruiting

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

Role: lead

NCT05903027Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Role: lead

NCT06409832Recruiting

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Role: lead

NCT07130929Not ApplicableRecruiting

Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study.

Role: collaborator

NCT04392908Active Not Recruiting

Communication Memory of Cancer Diagnosis Within the Pediatric Triangle

Role: collaborator

NCT04134598Phase 3Active Not Recruiting

ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer

Role: collaborator

NCT04791540Recruiting

Sarcopenia and Nutritional Status in a Rehabilitation Setting

Role: collaborator

NCT07120958Enrolling By Invitation

The Impact of Uterine Immunity and Its Alterations on the Embryo Implantation Process

Role: collaborator

NCT07083050Not ApplicableRecruiting

Non-Inferiority of Fibroguide Collagen Membrane Compared to Autologous Connective Tissue Graft for Coverage of Multiple Adjacent Recession. Multicenter Trial.

Role: collaborator